From: Management of orbital invasion in esthesioneuroblastoma: 14 years’ experience
Variable | 5-year OS | 5-year PFS | 5-year LRFS | 5-year DMFS | ||||
---|---|---|---|---|---|---|---|---|
% | p | % | p | % | p | % | p | |
Age | ||||||||
> 55 | 76.1 | 0.201 | 65 | 0.596 | 74.8 | 0.877 | 86.8 | 0.371 |
≤ 55 | 61.9 | 48.8 | 68 | 72.7 | ||||
Sex | ||||||||
Male | 70.4 | 0.461 | 56.4 | 0.739 | 65.9 | 0.168 | 84 | 0.101 |
Female | 64 | 58.3 | 93.8 | 70 | ||||
Degree of orbital invasiona | ||||||||
Grade I | 100 | 0.043* | 91.7 | 0.041* | 91.7 | 0.223 | 100 | 0.121 |
Grade II/III | 61.4 | 49.2 | 66.8 | 75.7 | ||||
Foote stage | ||||||||
C | 72.3 | 0.026* | 61.7 | 0.046* | 73.9 | 0.449 | 84.6 | 0.009* |
D | 50 | 37.5 | 64.3 | 57.1 | ||||
Lymph node classification | ||||||||
N0 | 72.3 | 0.026* | 61.7 | 0.046* | 73.9 | 0.449 | 84.6 | 0.009* |
N+ | 50 | 37.5 | 64.3 | 57.1 | ||||
Invasion of orbital apex or optic nerve | ||||||||
Yes | 62.3 | 0.173 | 53 | 0.154 | 80.8 | 0.849 | 80.8 | 0.387 |
No | 70.2 | 59.4 | 71.4 | 81.5 | ||||
Chemotherapy | ||||||||
Yes | 65.5 | 0.335 | 63.9 | 0.216 | 80.3 | 0.016* | 78.4 | 0.372 |
No | 80.2 | 37.9 | 50.5 | 87.5 | ||||
Surgical methods | ||||||||
Endoscopic group | 73.8 | 0.796 | 54.5 | 0.358 | 68.1 | 0.268 | 84.6 | 0.8 |
Open groupb | 67.7 | 46.2 | 59.2 | 80 | ||||
Treatment methods | ||||||||
Radical radiation | 63.5 | 0.847 | 69.3 | 0.394 | 83.9 | 0.407 | 83.1 | 0.885 |
Radiation + surgery | 70.7 | 53.8 | 66.3 | 80.2 | ||||
Type of radiotherapy | ||||||||
3D-CRT | 60.2 | 0.077 | 46.9 | 0.032* | 67.7 | 0.277 | 71.6 | 0.028* |
IMRT | 89.7 | 79.6 | 82.8 | 100 | ||||
PENI | ||||||||
Yes | 80.5 | 0.689 | 81.8 | 0.039* | 100 | 0.004* | 85.3 | 0.762 |
No | 70.1 | 50 | 58.1 | 85.7 |